| Followers | 19 |
| Posts | 6542 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Friday, April 02, 2021 1:44:26 AM
WQLF SAYS
According to the time frame and cost of trials according to the recent 2020 Annual Report it is going to be a long time and the continuation of burning monies from the continuation of diluted Stock to even get close to your 150 Billion projection YQU Understand. Even if Mind Med is successful the cost of the drugs will be very difficult in my opinion to even get approved for Medicaid in any or all individual states. Most of those individuals that want or need to recover from one drug only to get Hooked on another drug will be a small portion of the population. Thus drug is not going out to the masses like a Bayer Aspirin YQU Understand. The Mind Med drugs if successful and approved by the FDA, due to its intimacy along with a small population of those that will be in need of such a drug it will be very expensive. Because Big Pharma is already in the process of similar drugs the WQLF doesn’t see how Mind Med or other small potatoes will ever be valued or worth anywhere near where you have projected YQU Understand. Imho Have Mercy Wolf Ahooooooo
WQLF Said; The WQLF was referring to the current Pps whereas MMQ is Qverpriced and Qvervalued YQU Understand. Have Mercy Wolf Ahooooooo
Dr. Joong J Fang Said; Most Drug Addicts are in the lower socioeconomic portion of the Population that cannot and will not be able to afford new high cost drugs, so it will be up to the companies to get approval by Medicaid which is very difficult to obtain.
Medicaid Prescription Drug Laws and Strategies
https://www.ncsl.org/research/health/medicaid-pharmaceutical-laws-and-policies.aspx
WQLFMAN JACK Said;
According to the time frame and cost of trials according to the recent 2020 Annual Report it is going to be a long time and the continuation of burning monies from the continuation of diluted Stock to even get close to your 150 Billion projection YQU Understand. Even if Mind Med is successful the cost of the drugs will be very difficult in my opinion to even get approved for Medicaid in any or all individual states. Most of those individuals that want or need to recover from one drug only to get Hooked on another drug will be a small portion of the population. Thus drug is not going out to the masses like a Bayer Aspirin YQU Understand. The Mind Med drugs if successful and approved by the FDA, due to its intimacy along with a small population of those that will be in need of such a drug it will be very expensive. Because Big Pharma is already in the process of similar drugs the WQLF doesn’t see how Mind Med or other small potatoes will ever be valued or worth anywhere near where you have projected YQU Understand. Imho Have Mercy Wolf Ahooooooo
SORRY WAY UNDERVALUED. SHOULD BE VALUED BETWEEN 10-15 This is a potential 150 billion PLUS COMPANY.
IT PAYS TO KNOW https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162946186
WQLF Said; The WQLF was referring to the current Pps whereas MMQ is Qverpriced and Qvervalued YQU Understand. Have Mercy Wolf Ahooooooo
Dr. Joong J Fang Said; Most Drug Addicts are in the lower socioeconomic portion of the Population that cannot and will not be able to afford new high cost drugs, so it will be up to the companies to get approval by Medicaid which is very difficult to obtain.
Medicaid Prescription Drug Laws and Strategies
https://www.ncsl.org/research/health/medicaid-pharmaceutical-laws-and-policies.aspx
WQLFMAN JACK Said;
Recent DFTX News
- New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States • Business Wire • 03/31/2026 11:00:00 AM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 03/30/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 10:43:44 PM
- Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026 • Business Wire • 03/26/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2026 09:41:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2026 09:40:41 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 03/09/2026 08:01:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (US) • 03/09/2026 02:50:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (Canada) • 03/09/2026 02:50:00 PM
- Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments • PR Newswire (Canada) • 02/27/2026 04:44:00 PM
- Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments • PR Newswire (US) • 02/27/2026 04:44:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:10:27 PM
- Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates • Business Wire • 02/26/2026 09:01:00 PM
- Definium Therapeutics to Participate at Upcoming Investor Conferences • Business Wire • 02/24/2026 12:01:00 PM
- Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 • Business Wire • 02/19/2026 09:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:21:24 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 01:42:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 09:54:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 09:53:18 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 02/02/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 12:30:27 PM
- Definium Therapeutics Appoints Roger Adsett to Board of Directors • Business Wire • 01/29/2026 12:00:00 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 01/26/2026 09:01:00 PM
- Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care • Business Wire • 01/20/2026 12:00:00 PM
- 2026 Asset Growth: Why Federal Compliance Is the New Metric • GlobeNewswire Inc. • 01/19/2026 05:20:49 PM
